$3.240
+0.072 (+2.21%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
X4 Pharmaceuticals Inc (XFOR) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting XFOR is Sell.
X4 Pharmaceuticals Inc (XFOR) 20-Day simple moving average is 3.02, while X4 Pharmaceuticals Inc (XFOR) share price is $—, making it Buy.
X4 Pharmaceuticals Inc (XFOR) 60-Day simple moving average is 3.43, while X4 Pharmaceuticals Inc (XFOR) share price is $—, making it Sell.
Technical Analysis for XFOR
AI Technical XFORAs of 2026-11-03, the technical board for X4 Pharmaceuticals Inc (XFOR) reads sell: 4 indicators are flashing buy, 5 are indicating sell, and 4 are neutral. Price at $3.24 sits below the 5-day, 10-day, 60-day and 200-day moving averages and above the 20-day.
Momentum readings: RSI stands at 53.237, MACD stands at 0.0409 (Buy), Stochastic %K stands at 75.81, Stochastic %D stands at 81.201 and CCI stands at 61.016.
XFOR trades below the 60-day SMA (3.43) and below the 200-day SMA (3.79). Immediate resistance sits at Classic R1 3.52, then R2 3.77. Support sits at Classic S1 2.99, then S2 2.71.
X4 Pharmaceuticals Inc (XFOR) Support & Resistance Level
X4 Pharmaceuticals Inc (XFOR) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 53.237 |
| STOCHk_14_3_3 | 75.810 |
| STOCHd_14_3_3 | 81.201 |
| CCI_20 | 61.016 |
| AO_5_34 | 0.271 |
| MOM_10 | 0.210 |
| MACD_12_26_9 | 0.041 |
X4 Pharmaceuticals Inc (XFOR) Relative Strength Index (RSI_14) is 53.237, creating a Neutral signal.
X4 Pharmaceuticals Inc (XFOR) Stochastic %K is 75.810, creating a Neutral signal.
X4 Pharmaceuticals Inc (XFOR) Stochastic %D is 81.201, creating a Sell signal.
X4 Pharmaceuticals Inc (XFOR) CCI_20 is 61.016, creating a Neutral signal.
X4 Pharmaceuticals Inc (XFOR) Awesome Oscillator (AO) is 0.271, creating a Buy signal.
X4 Pharmaceuticals Inc (XFOR) Momentum (MOM) is 0.210, creating a Buy signal.
X4 Pharmaceuticals Inc (XFOR) Moving Average Convergence Divergence (MACD) is 0.041, creating a Buy signal.
X4 Pharmaceuticals Inc (XFOR) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.290 | Sell |
| MA_10 | 3.274 | Sell |
| MA_20 | 3.016 | Buy |
| MA_60 | 3.426 | Sell |
| MA_200 | 3.795 | Sell |
| MA_250 | 3.794 | Sell |
X4 Pharmaceuticals Inc (XFOR) 5-Day simple moving average is 3.290, while X4 Pharmaceuticals Inc (XFOR) share price is $, making it a Sell.
X4 Pharmaceuticals Inc (XFOR) 10-Day simple moving average is 3.274, while X4 Pharmaceuticals Inc (XFOR) share price is $, making it a Sell.
X4 Pharmaceuticals Inc (XFOR) 20-Day simple moving average is 3.016, while X4 Pharmaceuticals Inc (XFOR) share price is $, making it a Buy.
X4 Pharmaceuticals Inc (XFOR) 60-Day simple moving average is 3.426, while X4 Pharmaceuticals Inc (XFOR) share price is $, making it a Sell.
X4 Pharmaceuticals Inc (XFOR) 200-Day simple moving average is 3.795, while X4 Pharmaceuticals Inc (XFOR) share price is $, making it a Sell.
X4 Pharmaceuticals Inc (XFOR) 250-Day simple moving average is 3.794, while X4 Pharmaceuticals Inc (XFOR) share price is $, making it a Sell.
Related articles
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
- AppLovin Q3 2026 Deep Dive: Beaten-Down S&P Dog Meets Axon Next-Gen Beat-and-Raise—and a $3.2B BuybaAppLovin Q3 2026: $2.185B rev (+55%), EPS $4.30 vs ~$4.03–4.04 Street, Adj EBITDA $1.842B (84%). Beat own guide $100M; Q4 $2.365–2.395B; auth +$3.2B; AH +22–24%.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.